KVUE
Kenvue Inc.
Is KVUE Halal?
Consumer-health and personal-care products are generally permissible at the activity level, with the current quantitative screen passing the examined asset-based limits and business-activity inputs remaining incomplete.
What You Should Know
Kenvue Inc. is a consumer-health company spun off from Johnson & Johnson, with Self Care, Skin Health and Beauty, and Essential Health brands including Tylenol, Listerine, Neutrogena, Aveeno and Band-Aid. Its March 29, 2026 Form 10-Q reports $26,854 million of total assets, $8,661 million of interest-bearing debt, $1,075 million of cash and equivalents and $2,501 million of trade receivables. Those inputs produce debt/assets of 32.25%, cash/assets of 4.00%, receivables plus cash/assets of 13.32%, and disclosed interest income/revenue of 0.28% for the quarter. The examined FTSE Yasaar, MSCI and Malaysia asset-ratio calculations pass their disclosed financial inputs; market-cap methods are not calculated without a licensed historical series. Consumer healthcare and personal care are generally permissible at the activity level, while formulations, litigation and the pending Kimberly-Clark transaction require qualitative review.
⚠️ Concerns
- •Kenvue discloses $11 million of interest income for the quarter, but no scholar-approved fixed purification percentage
- •Some product formulations may contain alcohol or animal-derived ingredients; investors who require halal-certified products should verify individual SKUs
- •Kenvue faces litigation and regulatory matters related to talc-based products, acetaminophen and other consumer-health claims
- •The pending Kimberly-Clark transaction could change the corporate perimeter and product mix
- •Ingredient sourcing, testing, marketing claims, product access and environmental impacts remain broader ethical topics
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-29; calculated 2026-07-13.
8,661 / 26,854
1,075 / 26,854
3,576 / 26,854
11 / 3,909
- Financial
- Pass
- Overall
- Incomplete
Debt is 32.25%, liquidity is 4.00%, receivables plus cash are 13.32% and disclosed interest income is 0.28%, below the examined FTSE limits. The business screen remains incomplete without a prohibited-revenue numerator.
- Financial
- Pass
- Overall
- Incomplete
Debt is 32.25%, liquidity is 4.00% and receivables plus cash are 13.32%, below the examined MSCI total-assets limits. The business screen remains incomplete because no universal prohibited-revenue numerator is disclosed.
- Financial
- Pass
- Overall
- Incomplete
Debt is 32.25% and liquidity is 4.00%, below the examined Malaysia SAC financial limits. The business screen remains incomplete because no universal prohibited-revenue numerator is disclosed.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible historical market-cap series is not stored, so these methods are not estimated from a current spot price.
Business-activity disclosure
Kenvue is a consumer-health company with personal-care, over-the-counter medicines, skin health, beauty and essential-health brands. Consumer healthcare and personal-care products are generally permissible at the activity level.
Limitation: The filing does not allocate a universal prohibited-revenue numerator by ingredient, product certification, customer use or brand; no exact prohibited-revenue percentage is asserted.
Purification
Kenvue discloses interest income but does not prescribe a scholar-approved purification percentage. Readers should follow the qualified scholar or methodology they use rather than applying an invented fixed rate.
Inputs, assumptions and primary sources
- Inputs use Kenvue's March 29, 2026 Form 10-Q; amounts are USD millions and revenue and interest income are for the fiscal three months.
- Debt uses total reported debt of $8,661 million: loans and notes payable of $1,589 million plus long-term debt of $7,072 million.
- Cash uses $1,075 million of cash and cash equivalents. No separate securities balance is used.
- Receivables use $2,501 million of trade receivables, excluding prepaid expenses and other receivables.
- Quarterly net sales are $3,909 million and disclosed interest income is $11 million; the screen does not infer a fixed purification rate.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →